CVE-2025-7639 AVEVA CVE debrief

Who should care

Defenders responsible for Enterprise SCADA systems, particularly those using Aveva products, should assess exposure and prioritize remediation. This includes operators of critical infrastructure, security teams managing access controls, and vulnerability management teams responsible for patching and mitigation efforts. The potential impact on operational continuity and security posture necessitates prompt attention and action.

Why it matters

CVE-2025-7639 is a medium-severity vulnerability that could allow an authenticated attacker to tamper with serialized data, potentially resulting in code execution. Defenders responsible for Enterprise SCADA systems, particularly those using Aveva products, should assess exposure and prioritize remediation.

• Potential code execution during deserialization
• Tampering with serialized data
• Privilege escalation within Enterprise SCADA security group 'DNA Apps'

Technical summary

The vulnerability, if exploited, could allow an authenticated miscreant with 'DNA Authority - Operator' privilege to tamper with serialized data, potentially resulting in code execution during deserialization under the privilege of Enterprise SCADA security group 'DNA Apps'. The attack requires prior authentication and is limited to the scope of the 'DNA Authority - Operator' privilege. Technical details on the vulnerability's exploitation are limited, but defenders should focus on validating affected product versions and applying patches or mitigations.

Defensive priority

Defenders should prioritize verifying the affected product versions, assessing exposure, and applying remediation if available.

Recommended defensive actions

• Verify affected Aveva product versions and assess exposure
• Apply remediation if available
• Monitor for potential exploitation attempts
• Review compensating controls for exposed systems
• Conduct an asset inventory to identify potentially vulnerable systems
• Track exceptions and retest remediated assets
• Implement source tracking for vulnerability-related events

Evidence notes

The CVE description and NVD entry provide limited information about the vulnerability, affected products, and potential impact. There is no explicit evidence of exploitation in the wild or specific details on the affected Aveva product versions. Defenders should verify the affected product versions, assess exposure, and apply remediation if available. The lack of detailed information on the vulnerability's scope and affected systems necessitates a cautious approach to ensure comprehensive mitigation.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.